Cases & Publications.

Filter

  • Article type

  • Analytical approach

  • Panaxea to investigate cost-effectiveness of innovative stem cell treatment for osteoarthritis

    News13 Oct 2020|

    As part of the international consortium of the AutoCRAT (Automated Cellular Robot-Assisted Technologies, grant no. 874671) project, Panaxea is evaluating the cost-effectiveness of an innovative robot-assisted platform to manufacture stem cells that can be used to treat osteoarthritis (OA) and possibly, in the future, also other diseases. Osteoarthritis is a disease affecting millions of people […]

  • Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness

    Publications5 Aug 2020|

    Research article published on BMC. 2020 August AUTHORS:  Sejal Patel, Melanie Lindenberg, Maroeska M. Rovers, Wim H. van Harten, Theo J.M. Ruers, Lieke Poot, Valesca P. Retel , Janneke P.C. Grutters. ABSTRACT Background: Treatment with tumor-Infiltrating Lymphocytes (TIL) is an innovative therapy for advanced melanoma with promising clinical phase I/II study results and likely beneficial […]

  • Early Cost-Effectiveness of Tumor Infiltrating Lymphocytes (TIL) for Second Line Treatment in Advanced Melanoma: A Model-Based Economic Evaluation

    Publications18 Jun 2020|

    Research article published on Pubmed. 2018 Seotember 15 AUTHORS: Valesca P Retèl, Lotte M G Steuten, Marnix H Geukes Foppen, Janne C Mewes, Melanie A Lindenberg, John B A G Haanen, Wim H van Harten. ABSTRACT Background: An emerging immunotherapy is infusion of tumor infiltrating Lymphocytes (TIL), with objective response rates of around 50% versus […]

  • Point-of-care diagnostic test for detecting influenza A/B and respiratory syncytial virus in the ER setting in Norway – A cost analysis

    Publications9 Jun 2020|

    Health Technology Assessment published on EUHEA conference. 2020 June 4 AUTHOR: Anne Voermans COAUTHORS: Janne Mewes, Tove Ofstad, Thorbjørn Halvorsen, Katalin Érsek, Lotte Steuten. ABSTRACT Objectives: In Norway an average of 1.7% of the population is being diagnosed with influenza every year. New point-of-care (POC) tests for influenza A/B and RSV are available with excellent […]

  • Geïntegreerde zorg succesvol implementeren is moeilijker dan een landing op de maan

    News13 Jan 2020|

    Het volgende artikel werd gepubliceerd in zorgwijzermagazine.be, 9 december 2019 TEKST: JENS DE WULF Op maandag 28 oktober was professor Bert Vrijhoef te gast bij Zorgnet-Icuro. Hij voerde er een vurig pleidooi voor geïntegreerde zorg. Vrijhoef, CEO bij Panaxea en verbonden aan de Universiteit van Maastricht en de Vrije Universiteit Brussel, lichtte zijn visie en […]

  • GEÏNTEGREERDE ZORG SUCCESVOL IMPLEMENTEREN IS MOEILIJKER DAN EEN LANDING OP DE MAAN

    News9 Dec 2019Bert Vrijhoef|
    Bert Vrijhoef

    GEÏNTEGREERDE ZORG SUCCESVOL IMPLEMENTEREN IS MOEILIJKER DAN EEN LANDING OP DE MAAN

Let us help you in making your innovation count.